Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan Read more about Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan
Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference Read more about Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update Read more about Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent Read more about Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent
Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time Read more about Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D Read more about Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting Read more about Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
Lantheus to Present at the 2025 Truist Securities MedTech Conference Read more about Lantheus to Present at the 2025 Truist Securities MedTech Conference
Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 Read more about Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update Read more about Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update
